149 related articles for article (PubMed ID: 34583196)
1. Establishment of a novel monoclonal antibody against truncated glycoforms of α-dystroglycan lacking matriglycans.
Yamasaki F; Umezawa F; Sensui T; Anzo M; Abo H; Kuo CW; Khoo KH; Kato K; Yagi H; Kawashima H
Biochem Biophys Res Commun; 2021 Nov; 579():8-14. PubMed ID: 34583196
[TBL] [Abstract][Full Text] [Related]
2. CDP-glycerol inhibits the synthesis of the functional
Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
[TBL] [Abstract][Full Text] [Related]
3. PCYT2 synthesizes CDP-glycerol in mammals and reduced PCYT2 enhances the expression of functionally glycosylated α-dystroglycan.
Imae R; Manya H; Tsumoto H; Miura Y; Endo T
J Biochem; 2021 Oct; 170(2):183-194. PubMed ID: 34255834
[TBL] [Abstract][Full Text] [Related]
4. Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals.
Imae R; Manya H; Endo T
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771084
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory machinery for the functional dystroglycan glycosylation.
Kondo Y; Okajima T
J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122
[TBL] [Abstract][Full Text] [Related]
6. Cancer Malignancy Is Correlated with Upregulation of PCYT2-Mediated Glycerol Phosphate Modification of α-Dystroglycan.
Umezawa F; Natsume M; Fukusada S; Nakajima K; Yamasaki F; Kawashima H; Kuo CW; Khoo KH; Shimura T; Yagi H; Kato K
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743105
[TBL] [Abstract][Full Text] [Related]
7. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan.
Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T
ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527
[TBL] [Abstract][Full Text] [Related]
8. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
Patnaik SK; Stanley P
J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
[TBL] [Abstract][Full Text] [Related]
9. Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.
Yagi H; Kuo CW; Obayashi T; Ninagawa S; Khoo KH; Kato K
Mol Cell Proteomics; 2016 Nov; 15(11):3424-3434. PubMed ID: 27601598
[TBL] [Abstract][Full Text] [Related]
10. Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function.
Sheikh MO; Capicciotti CJ; Liu L; Praissman J; Ding D; Mead DG; Brindley MA; Willer T; Campbell KP; Moremen KW; Wells L; Boons GJ
Nat Commun; 2022 Jun; 13(1):3617. PubMed ID: 35750689
[TBL] [Abstract][Full Text] [Related]
11. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals.
Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T
J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954
[TBL] [Abstract][Full Text] [Related]
12. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
Zhang P; Hu H
Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
[TBL] [Abstract][Full Text] [Related]
13. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
Elife; 2016 Apr; 5():. PubMed ID: 27130732
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
15. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
[TBL] [Abstract][Full Text] [Related]
16. Exploring the In situ pairing of human galectins toward synthetic O-mannosylated core M1 glycopeptides of α-dystroglycan.
Villones LL; Ludwig AK; Kumeta H; Kikuchi S; Ochi R; Aizawa T; Nishimura SI; Gabius HJ; Hinou H
Sci Rep; 2022 Oct; 12(1):17800. PubMed ID: 36274065
[TBL] [Abstract][Full Text] [Related]
17. Glycoproteomic characterization of recombinant mouse α-dystroglycan.
Harrison R; Hitchen PG; Panico M; Morris HR; Mekhaiel D; Pleass RJ; Dell A; Hewitt JE; Haslam SM
Glycobiology; 2012 May; 22(5):662-75. PubMed ID: 22241827
[TBL] [Abstract][Full Text] [Related]
18. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
[TBL] [Abstract][Full Text] [Related]
19. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.
Stalnaker SH; Hashmi S; Lim JM; Aoki K; Porterfield M; Gutierrez-Sanchez G; Wheeler J; Ervasti JM; Bergmann C; Tiemeyer M; Wells L
J Biol Chem; 2010 Aug; 285(32):24882-91. PubMed ID: 20507986
[TBL] [Abstract][Full Text] [Related]
20. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
